Page 29

Nevirapine, Aspen Lamivudine, Aspen Zidovudine, Aspen Lamzid (combination Lamivudine/Zidovudine) and the Aspen Lamzid/Nevirapine combo pack. New products launched during the year include Aspen Stavudine 15mg, Nevirapine suspension and the combo pack. Aspen’s representation in the ARV market was further enhanced by a deal signed with Merck Sharp and Dohme in September 2005 for a voluntary licence in respect of the generic, Efavirenz. This product is currently under technical development. An agreement has also been concluded with Bristol-Myers Squibb for the technology transfer and manufacture of a generic version of the new generation ARV, Atazanavir. Aspen has also been active in the ARV related infectious disease category and has concluded a deal with Lupin in India to collaborate in the tuberculosis market in South Africa. The deal provides Aspen with access to first line tuberculosis drugs for the South African market. Exports up at FCC FCC posted a strong volume driven performance for the year despite the Rand strength which endured for most of the period. Results were boosted by the launch of a new API, Fentanyl, which is in the process of being registered by several finished dose-form formulators across Europe (80 market authorisations in 27 European Union countries) and is showing good potential for the 2007 financial year. Other core APIs including Paracetamol, Codeine and Azathioprine continued to grow in volume. Exports (primarily USA and Europe) made up 51% of turnover as opposed to 41% in the prior year. Customer service levels have improved as a result of increased safety stock levels. Continued investment in building a new API pipeline is scheduled to deliver benefits from 2009 onwards. The joint venture with Matrix (in terms of which 50% of the FCC business was sold to Matrix) took effect from 1 January 2006 and benefits ranging from shared technologies, expanded product development capabilities and increased customer and territory coverage are expected. After eliminating intra-Group transactions and based upon 50% ownership for the second 6 months, FCC contributed R38 million to Group EBITA.

25

Aspen Annual Report 2006

Profile for Aspen Holdings

Aspen Annual Report 2006  

Aspen Annual Report 2006